SCHEMBL29432802

SCHEMBL29432802

O=[N+]([O-])c1ccc(F)nc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 6/20 0.47
ATM Q13315 1/20 0.47
ALDH1A1 P00352 5/20 0.41
HIF1A Q16665 2/20 0.41
TSHR P16473 4/20 0.39
CYP3A4 P08684 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
VCAM1 P19320 1/20 0.38
CASP6 P55212 1/20 0.38
MAPK1 P28482 3/20 0.38
TXNRD1 Q16881 2/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
CES1 P23141 1/20 0.38
PDE10A Q9Y233 1/20 0.37
MAPT P10636 3/20 0.37
POLB P06746 1/20 0.37
GPR35 Q9HC97 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL909014 1.00 TDP1 (0.47) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL15221112 0.81 TDP1 (0.42) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL2258709 0.81 TSHR (0.44) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL30072914 0.81 TSHR (0.44) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL1749639 0.81 TDP1 (0.44) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL31364996 0.78 TDP1 (0.44) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL30890730 0.78 CTSB (0.53) TDP1ATMALDH1A1TSHRCYP3A4
SCHEMBL9982714 0.78 CTSB (0.53) TDP1ATMALDH1A1TSHRCYP3A4
SCHEMBL6990761 0.78 MAPT (0.49) TDP1ATMALDH1A1HIF1ATSHR
SCHEMBL6837266 0.78 CTSB (0.42) TDP1ATMALDH1A1HIF1ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665456-A1 BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) Arvinas Operations, Inc. (US) 2025-12-24 EP disclosed
WO-2025109540-A1 MACROCYCLIC COMPOUNDS AS KIF18A INHIBITORS AURIGENE ONCOLOGY LIMITED (IN) 2025-05-30 WO disclosed
WO-2025096771-A1 MODULATORS OF BCL6 AS LIGAND DIRECTED DEGRADERS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-05-08 WO disclosed
WO-2025072629-A1 BENZIMIDAZOLE AND BENZIMIDAZOLONE BASED PROTAC COMPOUNDS FOR THE TARGETED DEGRADATION OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) ARVINAS OPERATIONS, INC. (US) 2025-04-03 WO disclosed
CN-115703765-B Substituted triazole derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2025-02-28 CN disclosed
CN-112469710-B Pyridyl and pyrazinyl- (aza) indole sulfonamides 优时比制药有限公司 2024-05-14 CN disclosed
EP-4291560-A1 TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS Jacobio Pharmaceuticals Co., Ltd. (CN) 2023-12-20 EP disclosed
CN-116848114-A Tricyclic derivatives useful as PARP7 inhibitors 北京加科思新药研发有限公司 2023-10-03 CN disclosed
CN-116615199-A Heterocyclic compounds as diacylglycerol kinase inhibitors and uses thereof 株式会社LG化学 2023-08-18 CN disclosed
WO-2022170974-A9 TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2023-03-30 WO disclosed
CN-115703765-A Substituted triazole derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2023-02-17 CN disclosed
WO-2022170974-A1 TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2022-08-18 WO disclosed
CN-113480476-B 4-fluoropyridine derivative and preparation method and application thereof 山东师范大学 2022-07-22 CN disclosed
CN-110734397-B Synthetic method of 4- (difluoromethyl) -2-hydroxypyridine-5-sulfonyl chloride 阿里生物新材料(常州)有限公司 2022-04-05 CN disclosed